Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Response to Letter to the Editor “Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?”

Epilepsy & Behavior(2020)10.1016/j.yebeh.2020.107512Source: DataRank Database

Response to Letter to the Editor “Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?” is a research paper published in Epilepsy & Behavior (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)OA: closedTopics (24)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Ahmed Sadek ORCID,Bernhard Greve,Paulette Williams ORCID,Julie Varner,Brian D. Moseley ORCID

Live enrichment

PubMed:33158738 OpenAlex:https://openalex.org/W3096426493

NIH

Nonin Medical

Biogen

NSF

NeuroPace

State of Alabama General Funds

Sunovion

Serina Therapeutics

Xenon Pharmaceuticals

Eisai

Greenwich Biosciences

UCB

Charles L. Shor Foundation for Epilepsy Research

Department of Defense

GW Pharma

LivaNova

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1525505020306922?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525505020306922?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.yebeh.2020.107512

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33158738

Fields of Study

Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchPharmacological Effects and Toxicity StudiesMedicine

MeSH Terms

HumansLorazepamPyrrolidinonesSeizuresAdministration, Intravenous

Keywords

LorazepamEpilepsyMedicineRandomized controlled trialAnesthesiaSeizure thresholdPsychiatryInternal medicineAnticonvulsantSafetyefficacyTolerabilityAntiepileptic DrugEpilepsy Monitoring UnitAcute Seizure

Sustainable Development Goals

SDG 0: Good health and well-being

Response to Letter to the Editor “Intravenous brivaracetam and lorazepam for acute seizure control: Are they equally effective?”

FAIR Checklist

Authors (6)

Funding (16 grants)

Open Access

Topics